➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
McKinsey
Boehringer Ingelheim
Dow
Express Scripts

Last Updated: October 29, 2020

DrugPatentWatch Database Preview

Torsemide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for torsemide and what is the scope of patent protection?

Torsemide is the generic ingredient in two branded drugs marketed by Roche, Am Regent, West-ward Pharms Int, Mylan Speciality Lp, Aurobindo Pharma, Corepharma, Hetero Labs Ltd Iii, Hikma, Par Pharm, Pliva Pharm Ind, Sun Pharm Inds, Teva, and Vintage Pharms, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for torsemide. Thirteen suppliers are listed for this compound.

Drug Prices for torsemide

See drug prices for torsemide

Drug Sales Revenue Trends for torsemide

See drug sales revenues for torsemide

Recent Clinical Trials for torsemide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 4
Duke UniversityPhase 4
National Heart, Lung, and Blood Institute (NHLBI)Phase 4

See all torsemide clinical trials

Pharmacology for torsemide
Paragraph IV (Patent) Challenges for TORSEMIDE
Tradename Dosage Ingredient NDA Submissiondate
DEMADEX TABLET;ORAL torsemide 020136

US Patents and Regulatory Information for torsemide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-002 Aug 23, 1993 DISCN Yes No   Start Trial   Start Trial   Start Trial
Vintage Pharms TORSEMIDE torsemide TABLET;ORAL 090613-001 Mar 22, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds TORSEMIDE torsemide TABLET;ORAL 078478-002 Feb 26, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Par Pharm TORSEMIDE torsemide TABLET;ORAL 076226-001 May 27, 2003 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for torsemide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche DEMADEX torsemide INJECTABLE;INJECTION 020137-002 Aug 23, 1993   Start Trial   Start Trial
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-002 Aug 23, 1993   Start Trial   Start Trial
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-004 Aug 23, 1993   Start Trial   Start Trial
Roche DEMADEX torsemide INJECTABLE;INJECTION 020137-002 Aug 23, 1993   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
McKesson
McKinsey
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.